MedRx Co., Ltd Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2018; Provides Earnings Guidance for the Six Months Ending June 2018 and Year Ending December 2018
For the six months ending June 2018, the company expects consolidated net sales to be JPY 0 million. Operating loss to be JPY 811 million. Ordinary loss to be JPY 809 million. Loss attributable to owners of parent to be JPY 793 million. Net loss per share to be JPY 89.21.
For the year ending December 2018, the company expects consolidated net sales to be JPY 698 million. Operating loss to be JPY 1,120 million. Ordinary loss to be JPY 1,115 million. Loss attributable to owners of parent to be JPY 1,100 million. Net loss per share to be JPY 123.79.